Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2649
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose ; day:9 ; month:10 ; year:2020 ; pages:1-7
Quality of life research ; (9.10.2020), 1-7
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11136-020-02639-7
- URN
-
urn:nbn:de:101:1-2020112423385133656048
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pinkawa, Michael
- Gharib, Amr
- Schlenter, Marsha
- Timm, Ludmila
- Eble, Michael J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer
Clinical outcome in metastatic prostate cancer after primary radiotherapy
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Surgery vs. radiotherapy in localized prostate cancer. Which is best?
Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer
Clinical outcome in metastatic prostate cancer after primary radiotherapy
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Surgery vs. radiotherapy in localized prostate cancer. Which is best?
Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer
Clinical outcome in metastatic prostate cancer after primary radiotherapy
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy